Efficacy and Safety of SPARC0921 in Subjects With Spasticity
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Men and women age 18 years and older
Known history of spasticity due to MS prior to starting baclofen
Able and willing to comply with the protocol, including availability for a scheduled clinic visits
Willingness and giving of written informed consent
In relapse or history of unstable course over the prior 30 days prior to the Screening Visit